Veeva Summit: Novo Nordisk’s ambitions for FPA to go live in one day

Novo Nordisk is hoping its partnerships with contract research organisations and vendors as well as the utilisation of AI will help in reducing trial set-up from final protocol approval (FPA) to go live to just one day.